nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 29th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 29th, 2022 11:26AM
|
Aug 29th, 2022 11:26AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 28th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 28th, 2022 04:25AM
|
Aug 28th, 2022 04:25AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 27th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 27th, 2022 03:45AM
|
Aug 27th, 2022 03:45AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 25th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 25th, 2022 08:25AM
|
Aug 25th, 2022 08:25AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 23rd, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 23rd, 2022 10:18AM
|
Aug 23rd, 2022 10:18AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 21st, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 21st, 2022 12:01PM
|
Aug 21st, 2022 12:01PM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 20th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 20th, 2022 01:38PM
|
Aug 20th, 2022 01:38PM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 19th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 19th, 2022 12:02PM
|
Aug 19th, 2022 12:02PM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 18th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 18th, 2022 03:45AM
|
Aug 18th, 2022 03:45AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|
nasdaq:arna
|
https://www.indeed.com/cmp/arena-pharmaceuticals
|
Aug 17th, 2022 12:00AM
|
Open
|
Arena Pharmaceuticals
|
|
Pharmaceutical
|
Arena Pharmaceuticals, Inc. is a biopharmaceutical company located in San Diego, California. The company is developing oral medications that target G-protein-coupled receptors. On June 27, 2012, the FDA approved lorcaserin, initially sold under the brand name Belviq with a launch sales force commitment of 200.
|
|
San Diego
|
|
|
|
3.70
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
15.00
|
15.00
|
3.60
|
3.80
|
3.10
|
3.50
|
3.80
|
|
|
|
|
|
|
|
|
|
Aug 17th, 2022 09:24AM
|
Aug 17th, 2022 09:24AM
|
Arena Pharmaceuticals
|
Health Care
|
Pharmaceuticals & Biotechnology
|